{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:09:47Z","timestamp":1781672987897,"version":"3.54.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":4513,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.amjoto.2012.01.006","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T08:02:16Z","timestamp":1329811336000},"page":"619-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia"],"prefix":"10.1016","volume":"33","author":[{"given":"Michael D.","family":"Otremba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart I.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina C.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hohuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Kveton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjoto.2012.01.006_bb0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archotol.1981.00790380012004","article-title":"Chronic ear infection in the immunodeficient patient","volume":"107","author":"Sasaki","year":"1981","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.intimp.2008.10.004","article-title":"A review of the current use of rituximab in autoimmune diseases.","volume":"9","author":"G\u00fcrcan","year":"2009","journal-title":"Intl Immunopharm"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0015","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0020","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell\u2013targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0025","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2010.03.025","article-title":"Does rituximab increase the incidence of infectious complications? A narrative review","volume":"15","author":"Kelesidis","year":"2011","journal-title":"Intl J Infect Dis"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0030","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/rheumatology\/ken234","article-title":"Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis","volume":"47","author":"Teichmann","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jcp.2009.068940","article-title":"Does rituximab aggravate pre-existing hypogammaglobulinaemia?","volume":"63","author":"Diwakar","year":"2010","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JCO.2005.05.282","article-title":"Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma","volume":"23","author":"Miles","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.23171","article-title":"The effects of rituximab on immunocompetency in patients with autoimmune disease","volume":"58","author":"Looney","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3899\/jrheum.090856","article-title":"Long term safety of patients receiving rituximab in rheumatoid arthritis clinical trials","volume":"37","author":"van Vollenhoven","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjoto.2012.01.006_bb0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.autrev.2006.03.010","article-title":"Common variable immune deficiency and autoimmunity","volume":"5","author":"Brandt","year":"2006","journal-title":"Autoimmun Rev"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070912000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070912000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:56:26Z","timestamp":1759294586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070912000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0196070912000300"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2012.01.006","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2012.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}